Weighted Average Number of Shares Outstanding, Diluted of Kronos Bio, Inc. from 31 Mar 2021 to 31 Mar 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Kronos Bio, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Mar 2021 to 31 Mar 2025.
  • Kronos Bio, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Mar 2025 was 60,807,000, a 2.2% increase year-over-year.
  • Kronos Bio, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 60,070,000, a 4% increase from 2023.
  • Kronos Bio, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 57,744,000, a 2.7% increase from 2022.
  • Kronos Bio, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 56,201,000, a 2.6% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Kronos Bio, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 60,807,000 +1,286,000 +2.2% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 60,070,000 +2,326,000 +4% 01 Oct 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY
Q3 2024 60,311,599 +2,165,293 +3.7% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 60,099,651 +2,701,720 +4.7% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 59,521,000 +2,374,000 +4.2% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 57,744,000 +1,543,000 +2.7% 01 Oct 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 58,146,306 +1,827,735 +3.2% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 57,397,931 +1,281,861 +2.3% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 57,147,000 +1,307,664 +2.3% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 56,201,000 +1,447,401 +2.6% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 56,318,571 +1,341,486 +2.4% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 56,116,070 +1,609,875 +3% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 55,839,336 +1,686,680 +3.1% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 54,753,599 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 54,977,085 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 54,506,195 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 54,152,656 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1

Kronos Bio, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 60,070,000 +2,326,000 +4% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025 2024 FY
2023 57,744,000 +1,543,000 +2.7% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
2022 56,201,000 +1,447,401 +2.6% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 54,753,599 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.